Ad5-yCD/mutTKSR39rep-hIL12
AXP000048.1 · Oncolytic virus
- Platform
- adenovirus (Ad5, replication-competent, IL-12-armed)
- Originator
- Henry Ford Health
- Sponsor
- Henry Ford Health
Names
| Name | Type | Source |
|---|---|---|
| Ad5-yCD/mutTKSR39rep-hIL12 | preferred name, code | curator, ncit |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5 (yCD/mutTKSR39rep-hIL12)
- Replication
- replicating
- Modifications
- replication-competent Ad5 carrying the suicide-gene fusion plus human IL-12
- Transgenes
- yCD/mutTK(SR39) suicide-gene fusion, IL12A, IL12B
- Route
- intratumoral
- Source
- evidence
Cross-references
- NCI Thesaurus
- C123930
Approvals
No regulatory approval recorded.
Clinical trials (2)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT03281382 | Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer | Completed | Phase 1 | 2017-07-01 | 2019-05-28 | 12 | Metastatic Pancreatic Cancer |
| NCT02555397 | Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer | Completed | Phase 1 | 2015-08 | 2019-06-16 | 15 | Prostate Cancer |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 37713401 | A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma. | PloS one | 2023 | cited by trial NCT02555397 |
NIH grants
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| R01CA160289 | Gene Therapy and Radiation Therapy for Prostate Cancer | HENRY FORD HEALTH SYSTEM | FREYTAG, SVEND O | 2012–2016 | name in abstract: Ad5-yCD/mutTKSR39rep-hIL12 |
Notes
Third-generation Henry Ford construct: the suicide-gene fusion plus human IL-12. Phase I trials in prostate cancer (NCT02555397) and metastatic pancreatic cancer (NCT03281382).
How to cite
Ad5-yCD/mutTKSR39rep-hIL12 (AXP000048.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000048.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.